Skip to content
LUNGevity Foundation· @LUNGevity · X·· 2026-04-19Score60

#LCSM

Reading

Lung cancer: perioperative IO and KRAS NSCLC

Body

With prostate cancer leading the way, radiopharmaceutical therapies are transforming how we treat cancer with precision.
@ZachMorrisMDPhD

@UWMadison
provides a great landscape view of the advantages + disadvantages of RPTs including manufacturing issues. #AACR26 #lcsm

Heat 2 · 0 likes · 0 replies · 2 reposts

Source: LUNGevity Foundation · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org